STIM — Neuronetics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1227636 ·
Last close
$2.74
Market Cap
$208.78M
52W High
$3.44
52W Low
$0.80
ADV30
1,239,223
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 41,568,000 | 21,223,000 | -1,501,000 | -3,439,000 | 131,529,000 | 19,197,000 | 109,889,000 |
| Mar 2026 | 34,454,000 | 16,154,000 | -8,995,000 | -10,790,000 | 125,440,000 | 13,214,000 | 108,380,000 |
| Dec 2025 | 41,777,000 | 21,704,000 | -5,043,000 | -7,158,000 | 141,551,000 | 28,134,000 | 115,311,000 |
| Sep 2025 | 37,297,000 | 17,108,000 | -7,321,000 | -9,045,000 | 145,465,000 | 27,971,000 | 114,105,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-12,802,000
Investing CF
$-754,000
Financing CF
$11,296,000
CapEx
$-779,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.54
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-469,577,000
Inventory
$4,715,000
Receivables
$16,210,000
ST Investments
$257,000
EBIT TTM
$-29,367,000
Pretax Income TTM
$-37,267,000
Interest Exp TTM
$7,900,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$155,096,000
EBITDA
$-19,263,000
Free Cash Flow
$345,625
Enterprise Value
$301,993,568
Total Cash
$19,197,000
Total Debt
$86,523,000
Shares Out
76,197,222
Trailing EPS
$-0.43
Book Value
$0.23
ROE
-116.1%
ROA
-10.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 149,157,000 | -31,436,000 | -38,998,000 | 141,551,000 | 115,311,000 | 22,378,000 | -20,374,000 |
| Dec 2024 | 74,890,000 | -34,563,000 | -43,708,000 | 140,903,000 | 109,104,000 | 27,706,000 | -30,997,000 |
| Dec 2023 | 71,348,000 | -30,554,000 | -30,189,000 | 115,831,000 | 81,641,000 | 34,190,000 | -32,038,000 |
| Dec 2022 | 65,206,000 | -35,111,000 | -37,159,000 | 116,884,000 | 59,824,000 | 57,060,000 | -30,739,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.34
Max Pain — expiry 2026-11-20
max pain strike: $2.00 · spot: $2.68 · call oi: 2,775 · put oi: 385
Expected Move to 2026-11-20:
±$1.27
(47.49%) —
implied range
$1.41 –
$3.96
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PROF | Profound Medical Corp. | $210.47M | $5.76 | — |
| PDEX | PRO DEX INC | $229.90M | $71.77 | — |
| ELMD | Electromed, Inc. | $233.25M | $27.88 | — |
| UTMD | UTAH MEDICAL PRODUCTS INC | $236.18M | $74.18 | — |
| INFU | InfuSystem Holdings, Inc | $253.15M | $12.71 | — |
News headlines (Yahoo Finance, 1h cache)
Neuronetics (STIM) Q2 2026 Earnings Call Transcript
2026-08-18 15:43 · Yahoo
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...
2026-08-11 21:02 · Yahoo
Neuronetics Q2 Earnings Call Highlights
2026-08-11 16:04 · Yahoo
Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase
2026-08-11 15:01 · Yahoo
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
2026-08-11 13:00 · Yahoo
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
2026-08-11 11:50 · Yahoo
Neuronetics and Jorey Chernett Announce Shared Vision
2026-08-03 12:00 · Yahoo
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
2026-07-28 12:32 · Yahoo
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
2026-07-20 20:05 · Yahoo
Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit
2026-07-14 18:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.